Mediwelcome Healthcare Management & Technology Inc. (HK:2159)
:2159
Want to see HK:2159 full AI Analyst Report?
2159 Stock Chart & Stats
HK$1.24
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.24
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.43 - HK$2.27
Previous CloseN/A
Volume32.00K
Average Volume (3M)143.19K
Market Cap
HK$490.00M
Enterprise ValueHK$343.35M
Total Cash (Recent Filing)HK$99.36M
Total Debt (Recent Filing)HK$54.49M
Price to Earnings (P/E)24.0
Beta0.56
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding280,000,000
10 Day Avg. Volume118,880
30 Day Avg. Volume143,186
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)2.15
Price to Sales (P/S)0.51
P/FCF Ratio96.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue & Profit RecoveryA 48% revenue rebound and a return to net profit in 2025 indicate the business regained demand traction and operating scale. If sustained, higher top-line momentum supports reinvestment, improves solvency prospects and underpins longer-term margin recovery versus prior loss years.
Improved LeverageLower leverage (D/E 0.49) versus the prior year gives the company greater financial flexibility and lower fixed interest burden. This structural improvement reduces refinancing risk and supports capacity to fund growth or absorb shocks without immediate equity dilution.
Return To Positive Cash GenerationPositive operating and free cash flow in 2025 demonstrate the company can convert sales into cash. Sustained cash generation enables organic funding for working capital and selective capex, lowering reliance on external financing if the trend persists.
Bears Say
Thin Operating ProfitabilityAn operating margin near break-even provides a very small buffer against cost shocks or modest revenue shortfalls. Structural margin weakness limits the company's ability to absorb rising costs, invest in product development, or build durable profitability without efficiency gains.
Unstable Cash-Flow HistoryA steep FCF decline and prior negative operating cash flow years show cash generation is inconsistent. This instability can force reliance on external financing for growth, elevate liquidity risk during downturns, and complicate multi-year strategic investments.
Earnings Volatility & Modest ROEHistoric swings from profit to large losses signal earnings volatility and uneven capital productivity. Modest ROE after recovery suggests the company has not consistently delivered strong returns on equity, which can hinder long-term capital attraction and strategic planning.
Mediwelcome Healthcare Management & Technology Inc. News
2159 FAQ
What was Mediwelcome Healthcare Management & Technology Inc.’s price range in the past 12 months?
Mediwelcome Healthcare Management & Technology Inc. lowest stock price was HK$0.42 and its highest was HK$2.27 in the past 12 months.
What is Mediwelcome Healthcare Management & Technology Inc.’s market cap?
Mediwelcome Healthcare Management & Technology Inc.’s market cap is HK$490.00M.
When is Mediwelcome Healthcare Management & Technology Inc.’s upcoming earnings report date?
Mediwelcome Healthcare Management & Technology Inc.’s upcoming earnings report date is Sep 02, 2026 which is in 102 days.
How were Mediwelcome Healthcare Management & Technology Inc.’s earnings last quarter?
Mediwelcome Healthcare Management & Technology Inc. released its earnings results on Mar 23, 2026. The company reported HK$0.083 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.083.
Is Mediwelcome Healthcare Management & Technology Inc. overvalued?
According to Wall Street analysts Mediwelcome Healthcare Management & Technology Inc.’s price is currently Overvalued.
Does Mediwelcome Healthcare Management & Technology Inc. pay dividends?
Mediwelcome Healthcare Management & Technology Inc. does not currently pay dividends.
What is Mediwelcome Healthcare Management & Technology Inc.’s EPS estimate?
Mediwelcome Healthcare Management & Technology Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mediwelcome Healthcare Management & Technology Inc. have?
Mediwelcome Healthcare Management & Technology Inc. has 280,000,000 shares outstanding.
What happened to Mediwelcome Healthcare Management & Technology Inc.’s price movement after its last earnings report?
Mediwelcome Healthcare Management & Technology Inc. reported an EPS of HK$0.083 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.526%.
Which hedge fund is a major shareholder of Mediwelcome Healthcare Management & Technology Inc.?
Currently, no hedge funds are holding shares in HK:2159
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Mediwelcome Healthcare Management & Technology Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.98%
12-Months-Change
Fundamentals
Return on Equity
11.07%
Trailing 12-Months
Asset Growth
2.72%
Trailing 12-Months
Company Description
Mediwelcome Healthcare Management & Technology Inc.
Mediwelcome Healthcare Management & Technology Inc. (2159) is a healthcare technology company that focuses on providing innovative management solutions and advanced technology services for the healthcare sector. The company operates across various sectors, including telemedicine, electronic health records (EHR), and healthcare analytics, aiming to improve patient outcomes and streamline healthcare operations. Mediwelcome is dedicated to enhancing the efficiency of healthcare providers through its core products, which include integrated healthcare management platforms and data analytics tools designed to optimize resource utilization and patient care.
Mediwelcome Healthcare Management & Technology Inc. (2159) Earnings & Revenues
Technical Analysis
EC Healthcare
―
Yidu Tech, Inc.
―
Beijing Airdoc Technology Co. Ltd. Class H
―
Wanjia Group Holdings Ltd.
―
NEUSOFT XIKANG HOLDINGS INC.
―